Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
NCT04131829Phase 2Recruiting
- Sponsor
- Yale University
- Start
- Oct 2019
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoxetine in obsessive compulsive disorder (OCD), sponsored by Yale University. Started Oct 2019; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04131829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04131829.